ILDs: pathogenesis and clinical features

Poster Discussion
Chairs: W. Wuyts (Leuven, Belgium), D. Israel-Biet (Paris, France)

Live patient and partner survey on pulmonary fibrosis J. W. Kraan, B. Van den Blink, L. M. Van den Toorn, M. Gerrits, M. Kap, H. C. Hoogsteden, M. S. Wijsenbeek (Rotterdam, Netherlands)
Beneficial effect of azithromycin in children with diffuse parenchymal lung disease C. Perisson, R. Epaud, M. Fayon, N. Nathan, G. Thouvenin, H. Corvol, A. Clement, RespiRare Group (Paris, Creteil, Bordeaux, France)
Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis D. Franzen, C. F. Clarenbach, D. Kyburz, T. D. Latshang, A. Ciurea, E. W. Russi, M. Kohler (Zurich, Basel, Switzerland)
Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Y. Miura, T. Saito, Y. Tsunoda, T. Tanaka, H. Takoi, Y. Yatagai, S. Y. Lin, A. Sekine, K. Hayashihara, M. Inomata, T. Nei, Y. Saito, A. Gemma, A. Azuma (Ibaraki, Tokyo, Japan)
Evolution of an interstitial lung disease MDT: 5.5 years of data N. Chaudhuri, L. Spencer, C. Leonard (Manchester, Liverpool, United Kingdom)
Lymphangioleiomyomatosis in TOSCA - TuberOus SClerosis registry to increAse disease awareness V. Cottin, J. C. Kingswood, M. Feucht, P. Bruzzi, T. Carter, P. Curatolo, P. J. De Vries, C. Fladrowski, C. Hertzberg, A. Jansen, S. Jozwiak, R. Nabbout, F. O'Callaghan, M. Sauter, R. Touraine, S. Youroukos, B. Zonnenberg, G. Beaure d'Augère, E. Belousova, M. Dahlin, J. C. Ferreira, J. Lawson, B. Perkovic, A. Macaya, V. Sander, S. Crippa, B. Ulker, R. Castellana (Lyon, Paris, Saint Etienne, Castelmaurou, France; Brighton, Nottingham, London, United Kingdom; Vienna, Austria; Genoa, Rome, Origgio, Italy; Cape Town, South Africa; Berlin, Munich, Germany; Brussels, Belgium; Warsaw, Poland; Athens, Greece; Utrecht, Netherlands; Moscow, Russian Federation; Stockholm, Sweden; Lisbon, Portugal; Randwick - Sydney, Australia; Ljubljana, Slovenia; Barcelona, Spain; Tallinn, Estonia; Basel, Switzerland)
Airway centered interstitial fibrosis – An under-recognized type of idiopathic interstitial pneumonia E. Silbernagel, A. Morresi-Hauff, W. Gesierich, M. Lindner, J. Behr, F. Reichenberger (Gauting, Munich, Germany)
Nintedanib prevents IL-1beta-stimulated proliferation of primary human lung fibroblasts from patients with idiopathic pulmonary fibrosis or from control donors F. Herrmann, L. Wollin (Biberach, Germany)
Pirfenidone and BIBF1120 regulate properties of myofibroblasts S. Lehtonen, H. Karvonen, E. Lappi-Blanco, R. Sormunen, U. Zagai, M. Sköld, R. Kaarteenaho (Oulu, Finland; Stockhom, Sweden)
Mucus production, lung inflammation and functional decay in IPF G. Turato, A. F. Floriani, S. Baraldo, E. Balestro, E. Bazzan, M. Schiavon, R. Cazzuffi, M. Damin, N. Nannini, F. Calabrese, F. Rea, M. Saetta, M. G. Cosio (Padova, Italy; Montreal, Canada)
Detection of helicobacter pylori by PCR in idiopathic pulmonary fibrosis (IPF) lung biopsies M. Kreuter, D. Kirsten, R. Penzel, U. Oltmanns, S. Ehlers-Tenenbaum, K. Palmowski, A. Traeger, P. A. Schnabel, C. P. Heussel, F. J. F. Herth, A. Warth (Heidelberg, Großhansdorf, Germany)
CD8+ T cells, dendritic cells, mast cells and FOXP3 in the lungs of patients with severe influenza A (H1N1) infection M. Buttignol, R. Pires-Neto, M. Ballarin, M. Dolhnikoff, T. Mauad (São Paulo, Brazil)
Mutation alone does not predict the clinical course of surfactant protein C deficiency in children C. Kröner, S. Reu, V. Teusch, A. C. Grimmelt, R. Zarbock, P. Lohse, F. Brasch, G. Matthias, Kids Lung Register SFPTC Study Group (Munich, Singen, Bielefeld, Germany)
Elevated protein arginine methyltransferase 1 expression contributes to the pathogenesis of pulmonary fibrosis D. Zakrzewicz, A. Zakrzewicz, M. Didiasova, K. T. Preissner, M. Wygrecka (Giessen, Germany)
PET-CT with 18F-FDG and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis B. Bondue, F. Sherer, O. Vosters, G. Van Simaeys, G. Doumont, M. Parmentier, S. Rorive, S. Lacrois, S. Goldman (Brussels, Charleroi, Belgium)
Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb S. Marwitz, G. Zissel, P. Zabel, C. Kugler, E. Vollmer, T. Goldmann (Borstel, Freiburg, Großhansdorf, Germany)
Lung 18F-FDG uptake correlates with lung function alteration in patients with IPF A. Justet, A. Laurent-Bellue, M. P. Debray, R. Borie, R. Lebtahi, B. Crestani (Paris, France)
Critical balance of TNF-a signaling in newborn mice undergoing mechanical ventilation T. Gimm, M. Kossert, M. Koschlig, C. M. Alvira, H. Ehrhardt, A. Hilgendorff (Munich, Giessen, Germany; Stanford, United States Of America)